Response of Hispanic Puerto Rican Multiple Sclerosis Patients Switched from High Efficacy Therapies to cladribine Tablets in a Real-World Setting

被引:0
|
作者
Chinea, Angel [1 ]
Vega-Corteguera, Ramon [2 ]
Martinez-Maldonado, Viviana [2 ]
Vicente, Ivonne [2 ]
Navedo-Santos, Jessenia [1 ]
机构
[1] San Juan MS Ctr, Guaynabo, PR USA
[2] Caribbean Ctr Clin Res, Guaynabo, PR USA
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
P1763/1031
引用
收藏
页码:1112 / 1112
页数:1
相关论文
共 50 条
  • [41] Efficacy and safety of alemtuzumab treatment in a real-world cohort of patients with multiple sclerosis
    Zmira, Ofir
    Halpern, Alex, I
    Abraham, Lital
    Achiron, Anat
    ACTA NEUROLOGICA BELGICA, 2021, 121 (06) : 1513 - 1518
  • [42] Real-World Effectiveness and Safety of Cladribine in Multiple Sclerosis: Longitudinal Data From the Nationwide Registry in Argentina
    Rojas, Juan Ignacio
    Alonso, Ricardo
    Luetic, Geraldine
    Patrucco, Liliana
    Casas, Magdalena
    Silva, Berenice
    Miguez, Jimena
    Deri, Norma
    Vrech, Carlos
    Liwacki, Susana
    Piedrabuena, Raul
    Silva, Emanuel
    Tkachuk, Veronica
    Burgos, Marcos
    Tavolini, Dario
    Zanga, Gisela
    Pinheiro, Amelia Alvez
    Hryb, Javier
    Leguizamon, Felisa
    Knorre, Eduardo
    Lopez, Pablo A.
    Martinez, Alejandra
    Carra, Adriana
    Serena, Marina Alonso
    Cristiano, Edgardo
    Correale, Jorge
    Garcea, Orlando
    Liguori, Nora Fernandez
    Contentti, Edgar Carnero
    CLINICAL NEUROPHARMACOLOGY, 2024, 47 (04) : 120 - 127
  • [43] CLASSIC-MS: Long-term Efficacy and Real-World Treatment Patterns for Patients with Relapsing Multiple Sclerosis who Received Cladribine Tablets in Phase III Parent Trials
    Giovannoni, Gavin
    Aydemir, Aida
    Di Cantogno, Elisabetta Verdun
    Leist, Thomas
    NEUROLOGY, 2021, 96 (15)
  • [44] Multiple Sclerosis Patients Treated with Diroximel Fumarate in the Real-World Setting have High Rates of Persistence and Adherence
    Liseno, J.
    Lager, B.
    Miller, C.
    Shankar, S. L.
    Mendoza, J. P.
    Lewin, J. B.
    MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (1_SUPPL) : 94 - 94
  • [45] Multiple Sclerosis Patients Treated with Diroximel Fumarate in the Real-World Setting have High Rates of Persistence and Adherence
    Liseno, Jacob
    Lager, Brittney
    Miller, Catherine
    Shankar, Sai L.
    Mendoza, Jason P.
    Lewin, James B.
    NEUROLOGY, 2021, 96 (15)
  • [46] Multiple Sclerosis Patients Treated With Diroximel Fumarate in the Real-World Setting Have High Rates of Persistence and Adherence
    Jacob Liseno
    Brittney Lager
    Catherine Miller
    Sai L. Shankar
    Jason P. Mendoza
    James B. Lewin
    Neurology and Therapy, 2021, 10 : 349 - 360
  • [47] Multiple Sclerosis Patients Treated With Diroximel Fumarate in the Real-World Setting Have High Rates of Persistence and Adherence
    Liseno, Jacob
    Lager, Brittney
    Miller, Catherine
    Shankar, Sai L.
    Mendoza, Jason P.
    Lewin, James B.
    NEUROLOGY AND THERAPY, 2021, 10 (01) : 349 - 360
  • [48] Long-term Efficacy of Cladribine Tablets in Patients with Relapsing-Remitting or Secondary Progressive Multiple Sclerosis: Analysis of Real World Data From the Italian Multiple Sclerosis Registry (CLARINET-MS)
    Patti, Francesco
    Visconti, Andrea
    Capacchione, Antonio
    Trojano, Maria
    NEUROLOGY, 2020, 94 (15)
  • [49] Assessing treatment response to oral drugs for multiple sclerosis in real-world setting: a MAGNIMS Study
    Ruggieri, Serena
    Prosperini, Luca
    Al-Araji, Sarmad
    Annovazzi, Pietro Osvaldo
    Bisecco, Alvino
    Ciccarelli, Olga
    De Stefano, Nicola
    Filippi, Massimo
    Fleischer, Vinzenz
    Evangelou, Nikos
    Enzinger, Christian
    Gallo, Antonio
    Garjani, Afagh
    Groppa, Sergiu
    Haggiag, Shalom
    Khalil, Michael
    Lucchini, Matteo
    Mirabella, Massimiliano
    Montalban, Xavier
    Pozzilli, Carlo
    Preziosa, Paolo
    Rio, Jordi
    Rocca, Maria A.
    Rovira, Alex
    Stromillo, Maria L.
    Zaffaroni, Mauro
    Tortorella, Carla
    Gasperini, Claudio
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2024, 95 (02): : 142 - 150
  • [50] Real-World Evidence With Five-Year Data (2017-2022) on the use of Cladribine Tablets in Patients With Multiple Sclerosis in England: An Updated Analysis From the CLARENCE Study
    Brownlee, Wallace
    Amin, Amerah
    Ashton, Luke
    Herbert, Alex
    MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 993 - 994